{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:35:37Z","timestamp":1789500937831,"version":"build-2803163510"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The rate at which atrial fibrillation (AF) patients experience a return of symptoms after catheter ablation is significant, and there are multiple risk factors involved. This research intends to perform a meta-analysis to explore the risk factors connected to the recurrence of AF in patients following catheter ablation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The PubMed, Cochrane Library, WOS, Embase, SinoMed, CNKI, Wanfang, and VIP databases were explored for studies from January 1, 2000 to August 10, 2021, and research meeting the established inclusion requirements was chosen. Two authors separately gathered details regarding the study structure. The strength of the link between various risk factors and AF returning after CA was evaluated using odds ratios. All statistical evaluations were conducted with RevMan5.3 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 44 articles and 62,674 patients were included. The OR for AF recurrence in patients with diabetes was 2.04 compared with the reference group (95% CI 1.51\u20132.76, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of lower left ventricular ejection fraction was 1.38 (95% CI 1.25\u20131.52, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of female was 1.34 (95% CI 1.18\u20131.52, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of increased age was 1.03 (95% CI 1.02\u20131.04, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of persistent AF was 1.72 (95% CI 1.58\u20131.87, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of AF duration over 2\u00a0years was 1.17 (95% CI 1.08\u20131.26, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of increased left atrial diameter (LAD) was 1.12 (95% CI 1.08\u20131.17, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of larger left atrial volume index (LAVi) was 1.02 (95% CI 1.01\u20131.03, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); that of higher hs-CRP was 1.19 (95% CI 1.04\u20131.36, <jats:italic>p<\/jats:italic>\u2009=\u20090.04); that of early recurrence (ER) was 3.22 (95% CI 2.74\u20133.77, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.00001); and that of long ablation duration was 1.00 (95% CI 0.98\u20131.02, <jats:italic>p<\/jats:italic>\u2009=\u20090.72). Heterogeneity and slight publication bias were observed for each factor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Evidence indicates that diabetes, low left ventricular ejection fraction, being female, older age, longer duration of atrial fibrillation, elevated high-sensitivity C-reactive protein levels, large left atrial dimension, large left atrial volume index, persistent atrial fibrillation, and exercise rehabilitation are factors that increase the chances of getting atrial fibrillation again after catheter ablation. However, the length of the ablation procedure does not relate to the recurrence of AF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43044-025-00605-7","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T08:33:20Z","timestamp":1736757200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk factors for the recurrence of atrial fibrillation after catheter ablation: a meta-analysis"],"prefix":"10.1186","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5916-6804","authenticated-orcid":false,"given":"Gonghao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"12","key":"605_CR1","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O\u2019Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S (2018) Heart disease and stroke statistics-2018 update: a report from the American heart association. Circulation 137(12):e67\u2013e492. https:\/\/doi.org\/10.1161\/CIR.0000000000000558","journal-title":"Circulation"},{"key":"605_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","volume":"6","author":"M Zoni-Berisso","year":"2014","unstructured":"Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S (2014) Epidemiology of atrial fibrillation: european perspective. Clin Epidemiol 6:213\u2013220. https:\/\/doi.org\/10.2147\/CLEP.S47385","journal-title":"Clin Epidemiol"},{"issue":"1","key":"605_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/europace\/eux275","volume":"20","author":"H Calkins","year":"2018","unstructured":"Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d\u2019Avila A, de Groot N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T (2018) 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace 20(1):157\u2013208. https:\/\/doi.org\/10.1093\/europace\/eux275","journal-title":"Europace"},{"issue":"6","key":"605_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","volume":"136","author":"DH Lau","year":"2017","unstructured":"Lau DH, Nattel S, Kalman JM, Sanders P (2017) Modifiable risk factors and atrial fibrillation. Circulation 136(6):583\u2013596. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023163","journal-title":"Circulation"},{"issue":"10","key":"605_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrcardio.2013.121","volume":"10","author":"J Dewire","year":"2013","unstructured":"Dewire J, Calkins H (2013) Update on atrial fibrillation catheter ablation technologies and techniques. Nat Rev Cardiol 10(10):599\u2013612. https:\/\/doi.org\/10.1038\/nrcardio.2013.121","journal-title":"Nat Rev Cardiol"},{"issue":"36","key":"605_CR6","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1093\/eurheartj\/ehu291","volume":"35","author":"LM Haegeli","year":"2014","unstructured":"Haegeli LM, Calkins H (2014) Catheter ablation of atrial fibrillation: an update. Eur Heart J 35(36):2454\u20132459. https:\/\/doi.org\/10.1093\/eurheartj\/ehu291","journal-title":"Eur Heart J"},{"issue":"6","key":"605_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.hrthm.2014.03.015","volume":"11","author":"RH Jiang","year":"2014","unstructured":"Jiang RH, Po SS, Tung R, Liu Q, Sheng X, Zhang ZW, Sun YX, Yu L, Zhang P, Fu GS, Jiang CY (2014) Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: mechanistic implications. Heart Rhythm 11(6):969\u2013976. https:\/\/doi.org\/10.1016\/j.hrthm.2014.03.015","journal-title":"Heart Rhythm"},{"issue":"21","key":"605_CR8","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1001\/jama.2020.23700","volume":"325","author":"JR Baman","year":"2021","unstructured":"Baman JR, Passman RS (2021) Atrial fibrillation. Jama 325(21):2218. https:\/\/doi.org\/10.1001\/jama.2020.23700","journal-title":"Jama"},{"key":"605_CR9","unstructured":"Wells GA (2010) The newcastle ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. In.,"},{"key":"605_CR10","unstructured":"Jaber W, Sabate X (2021) Cochrane Handbook for Systematic Reviews of Interventions Version 6.2,. In: The Cochrane Collaboration,"},{"issue":"11","key":"605_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"5","key":"605_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/ije\/dyn065","volume":"37","author":"NA Patsopoulos","year":"2008","unstructured":"Patsopoulos NA, Evangelou E, Ioannidis JP (2008) Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 37(5):1148\u20131157. https:\/\/doi.org\/10.1093\/ije\/dyn065","journal-title":"Int J Epidemiol"},{"key":"605_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.009294","author":"S Arora","year":"2018","unstructured":"Arora S, Lahewala S, Tripathi B, Mehta V, Kumar V, Chandramohan D, Lemor A, Dave M, Patel N, Patel NV, Palamaner Subash Shantha G, Viles-Gonzalez J, Deshmukh A (2018) Causes and predictors of readmission in patients with atrial fibrillation undergoing catheter ablation: a national population-based cohort study. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.118.009294","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"605_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.hroo.2020.04.006","volume":"1","author":"A Wang","year":"2020","unstructured":"Wang A, Truong T, Black-Maier E, Green C, Campbell KB, Barnett AS, Febre J, Loring Z, Al-Khatib SM, Atwater BD, Daubert JP, Frazier-Mills C, Hegland DD, Jackson KP, Jackson LR, Koontz JI, Lewis RK, Pokorney SD, Sun AY, Thomas KL, Bahnson TD, Piccini JP (2020) Catheter ablation of atrial fibrillation in patients with diabetes mellitus. Heart Rhythm O2 1(3):180\u2013188. https:\/\/doi.org\/10.1016\/j.hroo.2020.04.006","journal-title":"Heart Rhythm O2"},{"issue":"10","key":"605_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1540-8167.2010.01786.x","volume":"21","author":"A Wokhlu","year":"2010","unstructured":"Wokhlu A, Hodge DO, Monahan KH, Asirvatham SJ, Friedman PA, Munger TM, Cha YM, Shen WK, Brady PA, Bluhm CM, Haroldson JM, Hammill SC, Packer DL (2010) Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol 21(10):1071\u20131078. https:\/\/doi.org\/10.1111\/j.1540-8167.2010.01786.x","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"605_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/circep.110.960690","volume":"4","author":"YM Cha","year":"2011","unstructured":"Cha YM, Wokhlu A, Asirvatham SJ, Shen WK, Friedman PA, Munger TM, Oh JK, Monahan KH, Haroldson JM, Hodge DO, Herges RM, Hammill SC, Packer DL (2011) Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol 4(5):724\u2013732. https:\/\/doi.org\/10.1161\/circep.110.960690","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"605_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/europace\/euv237","volume":"18","author":"PD Dallaglio","year":"2016","unstructured":"Dallaglio PD, Anguera I, Jimenez-Candil J, Peinado R, Garcia-Seara J, Arcocha MF, Macias R, Herreros B, Quesada A, Hernandez-Madrid A, Alvarez M, Di Marco A, Filgueiras D, Matia R, Cequier A, Sabate X (2016) Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation. Europace 18(6):873\u2013880. https:\/\/doi.org\/10.1093\/europace\/euv237","journal-title":"Europace"},{"issue":"4","key":"605_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.hrthm.2014.02.002","volume":"11","author":"S Deftereos","year":"2014","unstructured":"Deftereos S, Giannopoulos G, Efremidis M, Kossyvakis C, Katsivas A, Panagopoulou V, Papadimitriou C, Karageorgiou S, Doudoumis K, Raisakis K, Kaoukis A, Alexopoulos D, Manolis AS, Stefanadis C, Cleman MW (2014) Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm 11(4):620\u2013628. https:\/\/doi.org\/10.1016\/j.hrthm.2014.02.002","journal-title":"Heart Rhythm"},{"key":"605_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ebiom.2018.08.034","volume":"35","author":"H Deng","year":"2018","unstructured":"Deng H, Shantsila A, Guo P, Potpara TS, Zhan X, Fang X, Liao H, Liu Y, Wei W, Fu L, Wu S, Xue Y, Lip GYH (2018) A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry. EBioMed 35:40\u201345. https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.034","journal-title":"EBioMed"},{"issue":"6\u20137","key":"605_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.acvd.2019.02.006","volume":"112","author":"H Deng","year":"2019","unstructured":"Deng H, Shantsila A, Xue Y, Bai Y, Guo P, Potpara TS, Zhan X, Fang X, Liao H, Wu S, Lip GYH (2019) Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry. Arch Cardiovasc Dis 112(6\u20137):420\u2013429. https:\/\/doi.org\/10.1016\/j.acvd.2019.02.006","journal-title":"Arch Cardiovasc Dis"},{"issue":"10","key":"605_CR21","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacep.2020.05.023","volume":"6","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, Cotter TG, Wazni OM, Elshazly MB, Kochar A, Wilner B, Patel D, Kanj M, Hussein A, Baranowski B, Cantillon D, Griffin B, Jaber W, Saliba WI (2020) Impact of nonalcoholic fatty liver disease on arrhythmia recurrence following atrial fibrillation ablation. JACC Clin Electrophysiol 6(10):1278\u20131287. https:\/\/doi.org\/10.1016\/j.jacep.2020.05.023","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"605_CR22","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.numecd.2021.03.004","volume":"31","author":"M Kaneko","year":"2021","unstructured":"Kaneko M, Nagata Y, Nakamura T, Mitsui K, Nitta G, Nagase M, Okata S, Watanabe K, Miyazaki R, Nagamine S, Hara N, Lee T, Nozato T, Ashikaga T, Goya M, Hirao K, Sasano T (2021) Geriatric nutritional risk index as a predictor of arrhythmia recurrence after catheter ablation of atrial fibrillation. Nutr Metab Cardiovasc Dis 31(6):1798\u20131808. https:\/\/doi.org\/10.1016\/j.numecd.2021.03.004","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"605_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.amjcard.2012.12.021","volume":"111","author":"DA Morris","year":"2013","unstructured":"Morris DA, Parwani A, Huemer M, Wutzler A, Bekfani T, Attanasio P, Friedrich K, K\u00fchnle Y, Haverkamp W, Boldt LH (2013) Clinical significance of the assessment of the systolic and diastolic myocardial function of the left atrium in patients with paroxysmal atrial fibrillation and low CHADS(2) index treated with catheter ablation therapy. Am J Cardiol 111(7):1002\u20131011. https:\/\/doi.org\/10.1016\/j.amjcard.2012.12.021","journal-title":"Am J Cardiol"},{"issue":"5","key":"605_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jcct.2018.06.005","volume":"12","author":"L Lambert","year":"2018","unstructured":"Lambert L, Marek J, Fingrova Z, Havranek S, Kuchynka P, Cerny V, Simek J, Burgetova A (2018) The predictive value of cardiac morphology for long-term outcome of patients undergoing catheter ablation for atrial fibrillation. J Cardiovasc Comput Tomogr 12(5):418\u2013424. https:\/\/doi.org\/10.1016\/j.jcct.2018.06.005","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"3","key":"605_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.acvd.2018.10.006","volume":"112","author":"H Deng","year":"2019","unstructured":"Deng H, Shantsila A, Guo P, Potpara TS, Zhan X, Fang X, Liao H, Liu Y, Wei W, Fu L, Xue Y, Wu S, Lip GYH (2019) Sex-related risks of recurrence of atrial fibrillation after ablation: insights from the Guangzhou atrial fibrillation ablation registry. Arch Cardiovasc Dis 112(3):171\u2013179. https:\/\/doi.org\/10.1016\/j.acvd.2018.10.006","journal-title":"Arch Cardiovasc Dis"},{"issue":"8","key":"605_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/europace\/eux173","volume":"20","author":"TH Kim","year":"2018","unstructured":"Kim TH, Lee JS, Uhm JS, Joung B, Lee MH, Pak HN (2018) High circulating adiponectin level is associated with poor clinical outcome after catheter ablation for paroxysmal atrial fibrillation. EP Europace 20(8):1287\u20131293. https:\/\/doi.org\/10.1093\/europace\/eux173","journal-title":"EP Europace"},{"issue":"6","key":"605_CR27","first-page":"592","volume":"20","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhang X, Wang F (2020) Construction of predictive model of recurrence in patients with nonvalvular atrial fibrillation after cryoplasty ablation. Cardio-Cerebrovasc Dis Prev Treat 20(6):592\u2013595","journal-title":"Cardio-Cerebrovasc Dis Prev Treat"},{"issue":"5","key":"605_CR28","doi-asserted-by":"publisher","first-page":"e001277","DOI":"10.1161\/jaha.114.001277","volume":"3","author":"J Park","year":"2014","unstructured":"Park J, Kim TH, Lee JS, Park JK, Uhm JS, Joung B, Lee MH, Pak HN (2014) Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation. J Am Heart Assoc 3(5):e001277. https:\/\/doi.org\/10.1161\/jaha.114.001277","journal-title":"J Am Heart Assoc"},{"key":"605_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2020.12.009","author":"T Shchetynska-Marinova","year":"2021","unstructured":"Shchetynska-Marinova T, Liebe V, Papavassiliu T, de Faria FA, Hetjens S, Sieburg T, Doesch C, Sigl M, Akin I, Borggrefe M, Hohneck A (2021) Determinants of arterial stiffness in patients with atrial fibrillation. Arch Cardiovasc Dis. https:\/\/doi.org\/10.1016\/j.acvd.2020.12.009","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"605_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10840-011-9590-0","volume":"32","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Rabbani AB, Oral H, Bach D, Morady F, Chugh A (2011) Left atrial volume and dominant frequency of atrial fibrillation in patients undergoing catheter ablation of persistent atrial fibrillation. J Interv Cardiac Electrophysiol 32(2):155\u2013161. https:\/\/doi.org\/10.1007\/s10840-011-9590-0","journal-title":"J Interv Cardiac Electrophysiol"},{"issue":"12","key":"605_CR31","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1177\/0300060518793807","volume":"46","author":"D Carballo","year":"2018","unstructured":"Carballo D, Noble S, Carballo S, Stirnemann J, Muller H, Burri H, Vuilleumier N, Talajic M, Tardif JC, Keller PF, Mach F, Shah D (2018) Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation. J Int Med Res 46(12):5183\u20135194. https:\/\/doi.org\/10.1177\/0300060518793807","journal-title":"J Int Med Res"},{"key":"605_CR32","doi-asserted-by":"publisher","unstructured":"Stabile G, Trines SA, Arbelo E, Dagres N, Brugada J, Kautzner J, Pokushalov E, Maggioni AP, Laroche C, Anselmino M, Beinart R, Traykov V, Blomstrom Lundqvist C, investigators E-EAFAL-TR (2019) Atrial fibrillation history impact on catheter ablation outcome Findings from the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry. Pacing Clin Electrophysiol 42(3): 313\u2013320 https:\/\/doi.org\/10.1111\/pace.13600","DOI":"10.1111\/pace.13600"},{"issue":"9","key":"605_CR33","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/ehjci\/jey060","volume":"19","author":"F Bisbal","year":"2018","unstructured":"Bisbal F, Alarc\u00f3n F, Ferrero-de-Loma-Osorio A, Gonz\u00e1lez-Ferrer JJ, Alonso C, Pach\u00f3n M, Tiz\u00f3n H, Cabanas-Grand\u00edo P, Sanchez M, Benito E, Teis A, Ruiz-Granell R, P\u00e9rez-Villacast\u00edn J, Vi\u00f1olas X, Arias MA, Vall\u00e9s E, Garc\u00eda-Campo E, Fern\u00e1ndez-Lozano I, Villuendas R, Mont L (2018) Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study. Eur Heart J Cardiovasc Imaging 19(9):1002\u20131009. https:\/\/doi.org\/10.1093\/ehjci\/jey060","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"19\u201320","key":"605_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00508-015-0816-5","volume":"127","author":"A Boh\u00f3","year":"2015","unstructured":"Boh\u00f3 A, Mi\u0161\u00edkov\u00e1 S, Spurn\u00fd P, Komanov\u00e1 E, Kerekani\u010d M, Hud\u00e1k M, Stan\u010d\u00e1k B (2015) A long-term evaluation of cryoballoon ablation in 205 atrial fibrillation patients: a single center experience. Wien Klin Wochenschr 127(19\u201320):779\u2013785. https:\/\/doi.org\/10.1007\/s00508-015-0816-5","journal-title":"Wien Klin Wochenschr"},{"issue":"10","key":"605_CR35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.hrthm.2020.05.013","volume":"17","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, Wazni OM, Harb S, Kanj M, Saliba WI, Jaber WA (2020) Higher baseline cardiorespiratory fitness is associated with lower arrhythmia recurrence and death after atrial fibrillation ablation. Heart Rhythm 17(10):1687\u20131693. https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.013","journal-title":"Heart Rhythm"},{"issue":"4","key":"605_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2459\/jcm.0000000000000631","volume":"19","author":"S Fredersdorf","year":"2018","unstructured":"Fredersdorf S, Fenzl C, Jungbauer C, Weber S, von Bary C, Dietl A, Seegers J, Maier LS, \u00dccer E (2018) Long-term outcomes and predictors of recurrence after pulmonary vein isolation with multielectrode ablation catheter in patients with atrial fibrillation. J Cardiovasc Med 19(4):148\u2013154. https:\/\/doi.org\/10.2459\/jcm.0000000000000631","journal-title":"J Cardiovasc Med"},{"issue":"3","key":"605_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ijcard.2014.08.008","volume":"176","author":"TH Kim","year":"2014","unstructured":"Kim TH, Park J, Park JK, Uhm JS, Joung B, Lee MH, Pak HN (2014) Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: an analysis of over 600-patients. Int J Cardiol 176(3):841\u2013846. https:\/\/doi.org\/10.1016\/j.ijcard.2014.08.008","journal-title":"Int J Cardiol"},{"issue":"3","key":"605_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.amjcard.2014.05.012","volume":"114","author":"P Kumar","year":"2014","unstructured":"Kumar P, Patel A, Mounsey JP, Chung EH, Schwartz JD, Pursell IW, Gehi AK (2014) Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation. Am J Cardiol 114(3):407\u2013411. https:\/\/doi.org\/10.1016\/j.amjcard.2014.05.012","journal-title":"Am J Cardiol"},{"issue":"12","key":"605_CR39","doi-asserted-by":"publisher","first-page":"e006659","DOI":"10.1161\/circep.118.006659","volume":"11","author":"M Linhart","year":"2018","unstructured":"Linhart M, Alarcon F, Borr\u00e0s R, Benito EM, Chipa F, Cozzari J, Caixal G, Enomoto N, Carlosena A, Guasch E, Arbelo E, Tolosana JM, Prat-Gonzalez S, Perea RJ, Doltra A, Sitges M, Brugada J, Berruezo A, Mont L (2018) Delayed gadolinium enhancement magnetic resonance imaging detected anatomic gap length in wide circumferential pulmonary vein ablation lesions is associated with recurrence of atrial fibrillation. Circ Arrhythm Electrophysiol 11(12):e006659. https:\/\/doi.org\/10.1161\/circep.118.006659","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"605_CR40","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/europace\/euv439","volume":"18","author":"C Teunissen","year":"2016","unstructured":"Teunissen C, Kassenberg W, van der Heijden JF, Hassink RJ, van Driel VJ, Zuithoff NP, Doevendans PA, Loh P (2016) Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study. Europace 18(9):1335\u20131342. https:\/\/doi.org\/10.1093\/europace\/euv439","journal-title":"Europace"},{"issue":"2","key":"605_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jce.14345","volume":"31","author":"HT Yu","year":"2020","unstructured":"Yu HT, Kim IS, Kim TH, Uhm JS, Kim JY, Joung B, Lee MH, Pak HN (2020) Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation. J Cardiovasc Electrophysiol 31(2):457\u2013464. https:\/\/doi.org\/10.1111\/jce.14345","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"605_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/europace\/euw376","volume":"20","author":"S Knecht","year":"2018","unstructured":"Knecht S, Pradella M, Reichlin T, M\u00fchl A, Bossard M, Stieltjes B, Conen D, Bremerich J, Osswald S, K\u00fchne M, Sticherling C (2018) Left atrial anatomy, atrial fibrillation burden, and P-wave duration-relationships and predictors for single-procedure success after pulmonary vein isolation. EP Europace 20(2):271\u2013278. https:\/\/doi.org\/10.1093\/europace\/euw376","journal-title":"EP Europace"},{"issue":"3","key":"605_CR43","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jjcc.2016.04.017","volume":"69","author":"JK Park","year":"2017","unstructured":"Park JK, Lee JY, Yang PS, Kim TH, Shin E, Park J, Uhm JS, Joung B, Lee MH, Pak HN (2017) Good responders to catheter ablation for long-standing persistent atrial fibrillation: clinical and genetic characteristics. J Cardiol 69(3):584\u2013590. https:\/\/doi.org\/10.1016\/j.jjcc.2016.04.017","journal-title":"J Cardiol"},{"issue":"19","key":"605_CR44","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2012.04.060","volume":"60","author":"RR Tilz","year":"2012","unstructured":"Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, Mathew S, Yoshiga Y, Wissner E, Kuck KH, Ouyang F (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the hamburg sequential ablation strategy. J Am Coll Cardiol 60(19):1921\u20131929. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.060","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"605_CR45","first-page":"385","volume":"21","author":"Y Liu","year":"2017","unstructured":"Liu Y, Fang L, Chen W, Wang J, Gao P, Cheng Z (2017) Fang Q (2017) The value of right ventricular function in predicting recurrence after ablation of atrial fibrillation. Chin J Cardiac Arrhythm 21(5):385\u2013391","journal-title":"Chin J Cardiac Arrhythm"},{"issue":"8","key":"605_CR46","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/jce.14607","volume":"31","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, Wazni OM, Kanj M, Elshazly M, Hussein AA, Patel DR, Trulock K, Wilner B, Baranowski B, Cantillon DJ, Varma N, Jaber W, Saliba WI (2020) Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol 31(8):1979\u20131986. https:\/\/doi.org\/10.1111\/jce.14607","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"605_CR47","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/europace\/eur131","volume":"13","author":"J Gu","year":"2011","unstructured":"Gu J, Liu X, Wang X, Shi H, Tan H, Zhou L, Gu J, Jiang W, Wang Y (2011) Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus. Europace 13(9):1256\u20131261. https:\/\/doi.org\/10.1093\/europace\/eur131","journal-title":"Europace"},{"issue":"1","key":"605_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5935\/abc.20130211","volume":"102","author":"C Kalil","year":"2014","unstructured":"Kalil C, Bartholomay E, Borges A, Gazzoni G, Lima E, Etchepare R, Moraes R, Sussenbach C, Andrade K, Kalil R (2014) Atrial fibrillation ablation by use of electroanatomical mapping: efficacy and recurrence factors. Arq Bras Cardiol 102(1):30\u201338. https:\/\/doi.org\/10.5935\/abc.20130211","journal-title":"Arq Bras Cardiol"},{"key":"605_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/europace\/18.suppl_1.i37c","volume":"18","author":"N Cabanelas","year":"2016","unstructured":"Cabanelas N, Carlosena-Remirez A, Benito EM, al. e, (2016) Usefulness of fibrosis quantification by magnetic resonance with late gadolinium enhancement in prediction of recurrence after atrial fibrillation ablation. EP Europace 18:37","journal-title":"EP Europace"},{"key":"605_CR50","doi-asserted-by":"publisher","first-page":"e920429","DOI":"10.12659\/MSM.920429","volume":"26","author":"L Shang","year":"2020","unstructured":"Shang L, Shao M, Guo Q, Xiaokereti J, Zhao Y, Lu Y, Zhang L, Tang B, Zhou X (2020) Association of obesity measures with atrial fibrillation recurrence after cryoablation in patients with paroxysmal atrial fibrillation. Med Sci Monit 26:e920429. https:\/\/doi.org\/10.12659\/MSM.920429","journal-title":"Med Sci Monit"},{"issue":"2","key":"605_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10840-011-9588-7","volume":"32","author":"L Yang","year":"2011","unstructured":"Yang L, Xiufen Q, Shuqin S, Yang Y, Ying S, Yanwei Y, Wei F, Dechun Y (2011) Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol 32(2):147\u2013154. https:\/\/doi.org\/10.1007\/s10840-011-9588-7","journal-title":"J Interv Card Electrophysiol"},{"issue":"3","key":"605_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00392-011-0383-3","volume":"101","author":"B Richter","year":"2012","unstructured":"Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, Bergler-Klein J, Binder T, Wojta J, G\u00f6ssinger HD (2012) Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol 101(3):217\u2013225. https:\/\/doi.org\/10.1007\/s00392-011-0383-3","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"605_CR53","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/europace\/eut076","volume":"15","author":"Y Sotomi","year":"2013","unstructured":"Sotomi Y, Inoue K, Ito N, Kimura R, Toyoshima Y, Masuda M, Iwakura K, Fujii K (2013) Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation. Europace 15(11):1581\u20131586. https:\/\/doi.org\/10.1093\/europace\/eut076","journal-title":"Europace"},{"issue":"2","key":"605_CR54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10840-020-00741-x","volume":"60","author":"G Hodges","year":"2021","unstructured":"Hodges G, Bang CN, Torp-Pedersen C, Hansen ML, Schjerning AM, Hansen J, Johannessen A, Gislason GH, Pallisgaard J (2021) Significance of early recurrence of atrial fibrillation after catheter ablation: a nationwide Danish cohort study. J Interv Card Electrophysiol 60(2):271\u2013278. https:\/\/doi.org\/10.1007\/s10840-020-00741-x","journal-title":"J Interv Card Electrophysiol"},{"issue":"9","key":"605_CR55","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.amjcard.2009.01.010","volume":"103","author":"T Koyama","year":"2009","unstructured":"Koyama T, Sekiguchi Y, Tada H, Arimoto T, Yamasaki H, Kuroki K, Machino T, Tajiri K, Zhu XD, Kanemoto M, Sugiyasu A, Kuga K, Aonuma K (2009) Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation. Am J Cardiol 103(9):1249\u20131254. https:\/\/doi.org\/10.1016\/j.amjcard.2009.01.010","journal-title":"Am J Cardiol"},{"issue":"1","key":"605_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40119-019-00158-2","volume":"9","author":"L Rottner","year":"2020","unstructured":"Rottner L, Bellmann B, Lin T, Reissmann B, Tonnis T, Schleberger R, Nies M, Jungen C, Dinshaw L, Klatt N, Dickow J, Munkler P, Meyer C, Metzner A, Rillig A (2020) Catheter ablation of atrial fibrillation: state of the art and future perspectives. Cardiol Ther 9(1):45\u201358. https:\/\/doi.org\/10.1007\/s40119-019-00158-2","journal-title":"Cardiol Ther"},{"key":"605_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007414","author":"ZU Asad","year":"2019","unstructured":"Asad ZU, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S (2019) Catheter ablation versus medical therapy for atrial fibrillation a systematic review and meta-analysis of randomized controlled trials. Circ-Arrhythm Elec. https:\/\/doi.org\/10.1161\/CIRCEP.119.007414","journal-title":"Circ-Arrhythm Elec"},{"key":"605_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx466","author":"JL Pallisgaard","year":"2018","unstructured":"Pallisgaard JL, Gislason GH, Hansen J, Johannessen A, Torp-Pedersen C, Rasmussen PV, Hansen ML (2018) Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehx466","journal-title":"Eur Heart J"},{"issue":"3","key":"605_CR59","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/joa3.12353","volume":"36","author":"R Pranata","year":"2020","unstructured":"Pranata R, Vania R, Raharjo SB (2020) Efficacy and safety of renal denervation in addition to pulmonary vein isolation for atrial fibrillation and hypertension-systematic review and meta-analysis of randomized controlled trials. J Arrhythm 36(3):386\u2013394. https:\/\/doi.org\/10.1002\/joa3.12353","journal-title":"J Arrhythm"},{"issue":"6","key":"605_CR60","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.amjcard.2019.12.037","volume":"125","author":"A Creta","year":"2020","unstructured":"Creta A, Providencia R, Adragao P, de Asmundis C, Chun J, Chierchia G, Defaye P, Schmidt B, Anselme F, Finlay M, Hunter RJ, Papageorgiou N, Lambiase PD, Schilling RJ, Combes S, Combes N, Albenque JP, Pozzilli P, Boveda S (2020) Impact of type-2 diabetes mellitus on the outcomes of catheter ablation of atrial fibrillation (European observational multicentre study). Am J Cardiol 125(6):901\u2013906. https:\/\/doi.org\/10.1016\/j.amjcard.2019.12.037","journal-title":"Am J Cardiol"},{"issue":"11","key":"605_CR61","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.hrthm.2008.08.011","volume":"5","author":"C Pappone","year":"2008","unstructured":"Pappone C, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Sacchi S, Mazzone P, Paglino G, Gulletta S, Sala S, Santinelli V (2008) Atrial fibrillation progression and management: a 5-year prospective follow-up study. Heart Rhythm 5(11):1501\u20131507. https:\/\/doi.org\/10.1016\/j.hrthm.2008.08.011","journal-title":"Heart Rhythm"},{"issue":"8","key":"605_CR62","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang A, Green JB, Halperin JL, Piccini JP Sr (2019) Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol 74(8):1107\u20131115. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"605_CR63","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.amjcard.2017.02.050","volume":"119","author":"TS Cherian","year":"2017","unstructured":"Cherian TS, Shrader P, Fonarow GC, Allen LA, Piccini JP, Peterson ED, Thomas L, Kowey PR, Gersh BJ, Mahaffey KW (2017) Effect of atrial fibrillation on mortality, stroke risk, and quality-of-life scores in patients with heart failure (From the outcomes registry for better informed treatment of atrial fibrillation [ORBIT-AF]). Am J Cardiol 119(11):1763\u20131769. https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.050","journal-title":"Am J Cardiol"},{"issue":"9","key":"605_CR64","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.amjcard.2010.06.053","volume":"106","author":"Wilton SB, Fundytus A, Ghali WA, Veenhuyzen GD, Quinn FR, Mitchell LB, Hill MD, Faris P, Exner DV","year":"2010","unstructured":"Wilton SB, Fundytus A, Ghali WA, Veenhuyzen GD, Quinn FR, Mitchell LB, Hill MD, Faris P, Exner DV (2010) Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. Am J Cardiol 106(9):1284\u20131291. https:\/\/doi.org\/10.1016\/j.amjcard.2010.06.053","journal-title":"Am J Cardiol"},{"key":"605_CR65","doi-asserted-by":"publisher","first-page":"686507","DOI":"10.3389\/fphys.2021.686507","volume":"12","author":"JH Lee","year":"2021","unstructured":"Lee JH, Kwon OS, Shim J, Lee J, Han HJ, Yu HT, Kim TH, Uhm JS, Joung B, Lee MH, Kim YH, Pak HN (2021) Left atrial wall stress and the long-term outcome of catheter ablation of atrial fibrillation: an artificial intelligence-based prediction of atrial wall stress. Front Physiol 12:686507. https:\/\/doi.org\/10.3389\/fphys.2021.686507","journal-title":"Front Physiol"},{"issue":"8","key":"605_CR66","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jacep.2020.04.035","volume":"6","author":"JW Park","year":"2020","unstructured":"Park JW, Yu HT, Kim TH, Uhm JS, Joung B, Lee MH, Pak HN (2020) Mechanisms of long-term recurrence 3 years after catheter ablation of atrial fibrillation. JACC Clin Electrophysiol 6(8):999\u20131007. https:\/\/doi.org\/10.1016\/j.jacep.2020.04.035","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"605_CR67","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/jce.15002","volume":"32","author":"T Takamiya","year":"2021","unstructured":"Takamiya T, Nitta J, Inaba O, Sato A, Inamura Y, Murata K, Ikenouchi T, Kono T, Takahashi Y, Goya M, Sasano T (2021) Impact of diagnosis-to-ablation time on non-pulmonary vein triggers and ablation outcomes in persistent atrial fibrillation. J Cardiovasc Electrophysiol 32(5):1251\u20131258. https:\/\/doi.org\/10.1111\/jce.15002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"605_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-320601","author":"YJ Park","year":"2022","unstructured":"Park YJ, Park JW, Yu HT, Kim TH, Uhm JS, Joung B, Lee MH, Pak HN (2022) Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs. Heart. https:\/\/doi.org\/10.1136\/heartjnl-2021-320601","journal-title":"Heart"},{"key":"605_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2020.02.137","author":"RM MacGregor","year":"2021","unstructured":"MacGregor RM, Khiabani AJ, Bakir NH, Manghelli JL, Sinn LA, Carter DI, Maniar HS, Moon MR, Schuessler RB, Melby SJ, Damiano RJ Jr (2021) Impact of age on atrial fibrillation recurrence following surgical ablation. J Thorac Cardiovasc Surg. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.02.137","journal-title":"J Thorac Cardiovasc Surg"},{"key":"605_CR70","doi-asserted-by":"publisher","first-page":"734204","DOI":"10.3389\/fcvm.2021.734204","volume":"8","author":"WC Lee","year":"2021","unstructured":"Lee WC, Wu PJ, Chen HC, Fang HY, Liu PY, Chen MC (2021) Efficacy and safety of ablation for symptomatic atrial fibrillation in elderly patients: a meta-analysis. Front Cardiovasc Med 8:734204. https:\/\/doi.org\/10.3389\/fcvm.2021.734204","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"605_CR71","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/pace.14347","volume":"44","author":"CH Lin","year":"2021","unstructured":"Lin CH, Chang SL, Lin YJ, Lo LW, Hu YF, Chung FP, Chao TF, Lin CY, Tuan TC, Liao JN, Kuo L, Chang TY, Li HY, Huang TC, Chuang CM, Vicera JJ, Chen SA (2021) Distribution of triggers foci and outcomes of catheter ablation in atrial fibrillation patients in different age groups. Pacing Clin Electrophysiol 44(10):1724\u20131732. https:\/\/doi.org\/10.1111\/pace.14347","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"605_CR72","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12872-021-02196-y","volume":"21","author":"CC Chen","year":"2021","unstructured":"Chen CC, Lee PT, Van Ba V, Chuang CM, Lin YJ, Lo LW, Hu YF, Chung FP, Lin CY, Chang TY, Vicera JJ, Huang TC, Liu CM, Wu CI, Lugtu IC, Jain A, Chang SL, Chen SA (2021) Comparison of lesion characteristics between conventional and high-power short-duration ablation using contact force-sensing catheter in patients with paroxysmal atrial fibrillation. BMC Cardiovasc Disord 21(1):387. https:\/\/doi.org\/10.1186\/s12872-021-02196-y","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"605_CR73","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/joa3.12590","volume":"37","author":"Y Waranugraha","year":"2021","unstructured":"Waranugraha Y, Rizal A, Firdaus AJ, Sihotang FA, Akbar AR, Lestari DD, Firdaus M, Nurudinulloh AI (2021) The superiority of high-power short-duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: a systematic review and meta-analysis study. J Arrhythm 37(4):975\u2013989. https:\/\/doi.org\/10.1002\/joa3.12590","journal-title":"J Arrhythm"},{"key":"605_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.amjcard.2021.07.052","volume":"159","author":"A Hermida","year":"2021","unstructured":"Hermida A, Diouf M, Kubala M, Fay F, Burtin J, Lallemand PM, Buiciuc O, Lieu A, Zaitouni M, Beyls C, Hermida JS (2021) Results and predictive factors after one cryoablation for persistent atrial fibrillation. Am J Cardiol 159:65\u201371. https:\/\/doi.org\/10.1016\/j.amjcard.2021.07.052","journal-title":"Am J Cardiol"},{"issue":"5","key":"605_CR75","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.hrthm.2014.02.003","volume":"11","author":"JS Steinberg","year":"2014","unstructured":"Steinberg JS, Palekar R, Sichrovsky T, Arshad A, Preminger M, Musat D, Shaw RE, Mittal S (2014) Very long-term outcome after initially successful catheter ablation of atrial fibrillation. Heart Rhythm 11(5):771\u2013776. https:\/\/doi.org\/10.1016\/j.hrthm.2014.02.003","journal-title":"Heart Rhythm"},{"issue":"5","key":"605_CR76","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/europace\/eur398","volume":"14","author":"CA Goudis","year":"2012","unstructured":"Goudis CA, Kallergis EM, Vardas PE (2012) Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. Europace 14(5):623\u2013630. https:\/\/doi.org\/10.1093\/europace\/eur398","journal-title":"Europace"},{"issue":"8","key":"605_CR77","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2014.06.1172","volume":"64","author":"K Nishida","year":"2014","unstructured":"Nishida K, Datino T, Macle L, Nattel S (2014) Atrial fibrillation ablation translating basic mechanistic insights to the patient. J Am Coll Cardiol 64(8):823\u2013831. https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1172","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"605_CR78","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.hrthm.2014.09.063","volume":"12","author":"G Ciconte","year":"2015","unstructured":"Ciconte G, Ottaviano L, Deasmundis C, Baltogiannis G, Conte G, Sieira J, Di Giovanni G, Saitoh Y, Irfan G, Mugnai G, Storti C, Montenero AS, Chierchia GB, Brugada P (2015) Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm 12(1):60\u201366. https:\/\/doi.org\/10.1016\/j.hrthm.2014.09.063","journal-title":"Heart Rhythm"},{"issue":"5","key":"605_CR79","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jacc.2005.08.077","volume":"47","author":"TSM Tsang","year":"2006","unstructured":"Tsang TSM, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB (2006) Prediction of cardiovascular outcomes with left atrial size - Is volume superior to area or diameter? J Am Coll Cardiol 47(5):1018\u20131023. https:\/\/doi.org\/10.1016\/j.jacc.2005.08.077","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"605_CR80","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.amjcard.2008.12.021","volume":"103","author":"AS Helms","year":"2009","unstructured":"Helms AS, West JJ, Patel A, Lipinski MJ, Mangrum JM, Mounsey JP, Dimarco JP, Ferguson JD (2009) Relation of left atrial volume from three-dimensional computed tomography to atrial fibrillation recurrence following ablation. Am J Cardiol 103(7):989\u2013993. https:\/\/doi.org\/10.1016\/j.amjcard.2008.12.021","journal-title":"Am J Cardiol"},{"issue":"1","key":"605_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/europace\/eux013","volume":"20","author":"A Njoku","year":"2018","unstructured":"Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D, Dominic P (2018) Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace 20(1):33\u201342. https:\/\/doi.org\/10.1093\/europace\/eux013","journal-title":"Europace"},{"key":"605_CR82","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jelectrocard.2021.04.005","volume":"66","author":"K Nakamura","year":"2021","unstructured":"Nakamura K, Takagi T, Kogame N, Asami M, Toyoda Y, Enomoto Y, Hara H, Moroi M, Noro M, Sugi K, Nakamura M (2021) Impact of atrial mitral and tricuspid regurgitation on atrial fibrillation recurrence after ablation. J Electrocardiol 66:114\u2013121. https:\/\/doi.org\/10.1016\/j.jelectrocard.2021.04.005","journal-title":"J Electrocardiol"},{"issue":"1","key":"605_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/joa3.12473","volume":"37","author":"N Nso","year":"2021","unstructured":"Nso N, Bookani KR, Metzl M, Radparvar F (2021) Role of inflammation in atrial fibrillation: a comprehensive review of current knowledge. J Arrhythm 37(1):1\u201310. https:\/\/doi.org\/10.1002\/joa3.12473","journal-title":"J Arrhythm"},{"issue":"3","key":"605_CR84","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.hroo.2021.03.011","volume":"2","author":"B Varghese","year":"2021","unstructured":"Varghese B, Feldman DI, Chew C, Valilis E, Blumenthal RS, Sharma G, Calkins H (2021) Inflammation, atrial fibrillation, and the potential role for colchicine therapy. Heart Rhythm O2 2(3):298\u2013303. https:\/\/doi.org\/10.1016\/j.hroo.2021.03.011","journal-title":"Heart Rhythm O2"},{"issue":"22","key":"605_CR85","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","volume":"60","author":"Y Guo","year":"2012","unstructured":"Guo Y, Lip GY, Apostolakis S (2012) Inflammation in atrial fibrillation. J Am Coll Cardiol 60(22):2263\u20132270. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.063","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"605_CR86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1157\/13084635","volume":"59","author":"A Hernandez Madrid","year":"2006","unstructured":"Hernandez Madrid A (2006) C-reactive protein and atrial fibrillation an old marker looking for a new target. Rev Esp Cardiol 59(2):94\u201398","journal-title":"Rev Esp Cardiol"},{"issue":"9","key":"605_CR87","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/europace\/euq155","volume":"12","author":"T Kurotobi","year":"2010","unstructured":"Kurotobi T, Iwakura K, Inoue K, Kimura R, Okamura A, Koyama Y, Toyoshima Y, Ito N, Fujii K (2010) A pre-existent elevated C-reactive protein is associated with the recurrence of atrial tachyarrhythmias after catheter ablation in patients with atrial fibrillation. Europace 12(9):1213\u20131218. https:\/\/doi.org\/10.1093\/europace\/euq155","journal-title":"Europace"},{"issue":"2","key":"605_CR88","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10840-020-00741-x","volume":"60","author":"G Hodges","year":"2021","unstructured":"Hodges G, Bang CN, Torp-Pedersen C, Hansen ML, Schjerning AM, Hansen J, Johannessen A, Gislason GH, Pallisgaard J (2021) Significance of early recurrence of atrial fibrillation after catheter ablation: a nationwide Danish cohort study. J Interv Card Electr 60(2):271\u2013278. https:\/\/doi.org\/10.1007\/s10840-020-00741-x","journal-title":"J Interv Card Electr"},{"issue":"10","key":"605_CR89","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/clc.20340","volume":"31","author":"H Tao","year":"2008","unstructured":"Tao H, Liu X, Dong J, Long D, Tang R, Zheng B, Kang J, Yu R, Tian Y, Ma C (2008) Predictors of very late recurrence of atrial fibrillation after circumferential pulmonary vein ablation. Clin Cardiol 31(10):463\u2013468. https:\/\/doi.org\/10.1002\/clc.20340","journal-title":"Clin Cardiol"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-025-00605-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-025-00605-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-025-00605-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T20:08:19Z","timestamp":1736798899000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-025-00605-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1186\/s43044-025-00605-7","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}